Edition:
United Kingdom

Sun Pharma Advanced Research Company Ltd (SPRC.NS)

SPRC.NS on National Stock Exchange of India

458.00INR
23 Feb 2018
Change (% chg)

Rs25.70 (+5.94%)
Prev Close
Rs432.30
Open
Rs435.50
Day's High
Rs490.00
Day's Low
Rs435.50
Volume
2,922,829
Avg. Vol
496,775
52-wk High
Rs532.00
52-wk Low
Rs272.00

Chart for

About

Sun Pharma Advanced Research Company Limited is engaged in the research and experimental development on natural sciences and engineering (Pharmacy). The Company operates through Pharmaceuticals Research & Development segment. Its programs include Xelpros, Elepsia XR, Baclofen GRS, Paclitaxel Injection Concentrate for Nanodispers... (more)
No analyst recommendations are available for .

Overall

Beta: 1.30
Market Cap(Mil.): Rs96,005.50
Shares Outstanding(Mil.): 246.90
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 83.93 16.60
EPS (TTM): -- -- --
ROI: -- 1.66 10.66
ROE: -- 2.58 14.30

BRIEF-Sun Pharma Advanced Research Gets Demand Notice For Assessment Yr 2014-15

Feb 23 Sun Pharma Advanced Research Company Ltd :

23 Feb 2018

BRIEF-India's Sun Pharma Advanced Research Co Dec Qtr Loss Narrows

Jan 29 Sun Pharma Advanced Research Company Ltd :

29 Jan 2018

BRIEF-Sun Pharma Advanced Research Co announces top-line results of action study for Baclofen GRS

* Announces top-line results of phase III efficacy study & duration of action study for Baclofen GRS

06 Oct 2017

Earnings vs. Estimates